PROCEPT BioRobotics Corporation increased revenue guidance for full year 2024. For the period, the Company projects revenue for the full year 2024 to be $213.5 million, which represents 57% growth over the Company?s prior year revenue. This compares to previous revenue guidance of $210.0 million.
PROCEPT BioRobotics Corporation
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59.73 USD | +2.82% |
|
-0.68% | +42.52% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.52% | 2.99B | |
-4.92% | 182B | |
-3.70% | 103B | |
-5.29% | 66.94B | |
+10.99% | 46.73B | |
-7.70% | 45.14B | |
+6.64% | 41.57B | |
+15.96% | 30.48B | |
+13.63% | 24.26B | |
-6.63% | 23.58B |
- Stock Market
- Equities
- PRCT Stock
- News PROCEPT BioRobotics Corporation
- Procept Biorobotics Corporation Increases Revenue Guidance for Full Year 2024